Although collaboration assumes a power-sharing arrangement by default, that is, collaborative governance always involves some degree of sharing responsibility for decision making and actions among 745355A RPXXX10.
Power and trust are two important issues of interorganizational relations in collaborative governance. This article develops a critical conceptual analysis of the dyadic relationship between power and trust in the context of collaborative governance. Three dynamic relationships and seven corresponding propositions are proposed regarding the shared sources of power and trust, the effects of power asymmetry and power sharing on trust building, and the influence of trust building on the management of power relationship in collaborative governance. These dyadic relations will help scholars and practitioners to deal with the dynamics brought forth by power and trust in collaboration.
Public–private collaborations have the potential to effectively respond to extreme events. However, traditional public–private collaborations that are usually led by governmental actors often encounter significant difficulties in a crisis. Based on a case study of a public–private collaboration dealing with COVID-19 in China, we explore how a private actor emerges as a leader to initiate and manage a public–private collaboration in the crisis, and how stakeholders in this collaboration work together to effectively handle the crisis. The findings indicate critical characteristics and contingencies when a private actor leads the cross-sector collaboration to effectively cope with uncertainties and deliver public services in crisis time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.